Protecting Consumer Safety Must Remain Top Priority in Drug Regulation
A balancing act: Making sure drugs are safe before going to market without hampering innovation.
April 23, 2011 /Medical PR News/ -- Protecting Consumer Safety Must Remain Top Priority in Drug Regulation
In recent years, there has been extensive debate concerning how much government oversight there should be over new drugs and medical devices. Some observers - principally those in the
No comments:
Post a Comment